Diligence memo · auto-generated · as of July 2, 2026

Lhotse Medical, Inc.

Lhotse Medical, Inc. looks fair against its niche peers and is active on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Lhotse Medical, Inc. operates in Healthtech, based in DALLAS.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Lhotse Medical, Inc. has raised $3.7M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.2M on 2023-12-22.

Most recent recorded round closed around 2025-04-25.

Valuation (modeled)modeled

Provath models Lhotse Medical, Inc. at approximately $4.8M (range $1.3M–$10M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.99× the median modeled value of Seed Healthtech companies in 2025–2027 (77 peers) — value vs value, same stage and era. Within the normal band (99% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 16 months.

Last raise 14 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round was 1.5× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 50% of Healthtech peers (2138 compared).

Modeled value ranks above 23% of those peers.

Closest niche peers: Headstart Health, Inc., eMAX Health 2.0 LLC, Ezer Health Holdings, Llc, Helius Medical Technologies, Inc., LaaSy Health HoldCo Inc..

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.